Ambar Protein Industries Limited has scheduled its 33rd Annual General Meeting for September 30, 2026. The company confirmed the record date for voting eligibility as September 24, 2026.

The Ambar Protein Industries Board seeks shareholder consent for transactions totaling ₹401 crore with Ankur Oil Industries, alongside remuneration variations for the Managing Director and Whole Time Director.

Key Agenda Items

The meeting will address both ordinary and special business items. Shareholders will vote on the adoption of financial statements for the year ended March 31, 2026, and the re-appointment of directors retiring by rotation.

Related-Party Transactions

The most material special business item involves approving related-party transactions under Section 188 of the Companies Act, 2013. The Company proposes to enter into the following arrangements with Ankur Oil Industries:

These transactions involve common partners among the Company’s directors, including Mr. Pradeep C Khetani and Mr. Jayprakash J Vachhani. The Board states these deals are conducted on an arm’s length basis.

Management Remuneration

Shareholders will decide on varying the remuneration of two key executives:

• Mr. Pradeep Chunilal Khetani (Managing Director): His current monthly draw is ₹1,75,000. The proposed variation allows his annual pay to exceed ₹1 crore or 5% of net profits, whichever is higher.
• Mr. Jayprakash J Vachhani (Whole Time Director): Similarly, his remuneration may exceed statutory limits pending shareholder approval.

Additionally, the meeting will approve a commission for Non-Executive Director Mr. Bharatbhai D Patel at 1% of net profits for five years starting October 1, 2026.

Voting and Book Closure Details

Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, along with section 91 of the Companies Act, 2013, the Register of Members and Share Transfer Books will remain closed from Thursday, September 24, 2026 to Wednesday, September 30, 2026 (both days inclusive).

Remote e-voting begins on September 27, 2026, at 9:00 am and ends on September 30, 2026, at 5:00 pm. The cut-off date for e-voting is Wednesday, September 23, 2026.

Ambar Protein Industries reported a substantial improvement in profitability for the first quarter of FY27, with net profit after tax rising to ₹3.75 crore compared to ₹0.75 crore in the corresponding period of FY26. This represents a year-on-year increase of over 400%, signaling a recovery in the company’s bottom line despite modest headwinds on the top line.

Revenue from operations for the quarter ended June 30, 2026, stood at ₹113.45 crore, a slight decline from ₹117.27 crore recorded in Q1FY25. For the full fiscal year ended March 31, 2026, the company logged total income from operations of ₹500.66 crore.

Financial Performance

The company’s pre-tax profit for the quarter was ₹5.11 crore, up from ₹1.47 crore in the previous year. No exceptional or extraordinary items were reported in the statement of profit and loss for either period. Earnings per share (basic and diluted) increased to ₹6.53 per equity share of face value ₹10 each, compared to ₹1.30 in Q1FY25.

What the Numbers Show

The divergence between revenue and profit trends highlights an improvement in operational efficiency or cost management during the quarter. While revenue contracted by approximately 3.3% year-on-year, net profit expanded more than fourfold. This suggests that fixed costs were better absorbed or input costs declined relative to selling prices, allowing margins to expand despite lower sales volume. The absence of exceptional items indicates that the profit growth was driven by core operational performance rather than one-off gains.